The company has transitioned from a non-banking financial company (NBFC) to a real estate firm focused on property development, leasing, and trading Transferable Development Rights (TDR). It generates revenue by selling development rights and managing real estate assets in the Haryana region.
The company possesses no identifiable moat. Its recent shift from a low-margin finance business to real estate development lacks any evidence of cost advantage or brand power, and the 0.3% average net margin indicates a complete lack of competitive protection.
The track record is poor; the company abandoned its core finance business after failing to achieve scale or competitive returns. Capital is now being deployed into land and TDR certificates, but the negative cash conversion suggests this capital is being tied up in illiquid assets without generating consistent cash flow.
The company's pivot from finance to real estate proved to be a value-destroying venture into a sector where they possessed no expertise. Capital became permanently trapped in illiquid land and TDR certificates that failed to find buyers, while the negative cash conversion cycle drained remaining liquidity. Regulatory non-compliance and frequent turnover in key management eventually led to a loss of institutional trust, leaving the company as a stagnant shell with no core operations and a depleted asset base.
RichFakir rates Ramsons Projects Ltd's business quality as poor — 39/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Ramsons Projects Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Ramsons Projects Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Ramsons Projects Ltd's fair value is about ₹30 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →